ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.472
Delayed Data
As of 4:02pm ET
 +0.0021 / +0.45%
Today’s Change
0.43
Today|||52-Week Range
1.16
-35.34%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.47
Today’s open0.48
Day’s range0.47 - 0.48
Volume170,055
Average volume (3 months)639,990
Market cap$42.4M
Dividend yield--
Data as of 4:02pm ET, 06/30/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
--Protea Biosciences G...0.000.00%
OPGNOpGen Inc+0.06+1.64%
ABACAoxin Tianli Group I...-0.04-2.80%
FSIFlexible Solutions I...+0.08+3.92%
Data as of 3:59pm ET, 06/30/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$9.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers